Publications
206
Citations
2,873
Est. group size
~4
Recurring co-author estimate
Active years
33
Publishing since 1993
Khalid Mumtaz's research centers on liver disease, particularly cirrhosis, liver transplantation, and hepatocellular carcinoma (liver cancer), with a strong focus on patient outcomes and complications. Recent work examines how diabetes medications (GLP-1 receptor agonists and SGLT-2 inhibitors) affect survival and disease progression in liver transplant recipients and patients with cirrhosis, alongside studies on liver disease during pregnancy, acute liver failure, and hepatitis B epidemiology. This research is largely clinical and outcomes-based, drawing on hospital and transplant center patient data.
Publication output has fluctuated over the past decade, dipping around 2019 and again in 2023-2024, but rebounded sharply in 2025, suggesting variable but currently active output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- S26 Risk of Biliary Diseases in Patients Treated With GLP-1 vs GLP-1/GI Receptor Agonists: A Real-World Comparative Analysis of Semaglutide and Tirzepatide
The American Journal of Gastroenterology · 2025
- Analyzing global research trends in hepatology during Coronavirus Disease 2019: a bibliometric analysis
Annals of Medicine and Surgery · 2025
- Acute liver failure etiology, clinical manifestation and outcomes in adults: Experience of tertiary care hospital in Karachi
World Journal of Critical Care Medicine · 2025
- 721: SGLT-2 INHIBITOR USE IN PATIENTS WITH DIABETES AND CIRRHOSIS IS ASSOCIATED WITH REDUCED LIVER-RELATED ADVERSE EVENTS AND IMPROVED SURVIVAL
Gastroenterology · 2025
- 890: SGLT-2 INHIBITOR THERAPY IN LIVER TRANSPLANT RECIPIENTS MAY REDUCE THE RISK OF DEVELOPING NEW HEPATOCELLULAR CARCINOMA
Gastroenterology · 2025
- 724: GLP-1 RECEPTOR AGONIST USE IN PATIENTS WITH TYPE 2 DIABETES AND CIRRHOSIS IS ASSOCIATED WITH IMPROVED SURVIVAL OUTCOMES
Gastroenterology · 2025
- Sa1512: OUTCOMES IN LIVER TRANSPLANT RECIPIENTS WITH TYPE 2 DIABETES; A COMPARISON OF GLP-1 RECEPTOR AGONISTS AND NONGLP-1 THERAPIES
Gastroenterology · 2025
- Basic principles of cohort studies and practical application in gastroenterological literature
Elsevier eBooks · 2025
- Heart of the Matter: Uncovering the Link Between Heart Failure and Cirrhosis Mortality
Digestive Diseases and Sciences · 2025
- Serologic noninvasive liver disease assessments: clinical utility and future potential
HepatoBiliary Surgery and Nutrition · 2025
- Sa1578 TREATMENT RESPONSE TO TERLIPRESSIN IS UNAFFECTED BY DOSE INTERRUPTIONS IN PATIENTS WITH HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY
Gastroenterology · 2024
- Identification of Financial Distressed Firms at Pakistan Stock Exchange Through Infusion of Corporate Social Responsibility Information into Altman Z-Score
NUML International Journal of Business & Management · 2023
- Mo1600 NINETY-DAY READMISSIONS FOR LIVER TRANSPLANT RECIPIENTS AT A QUARTERNARY TRANSPLANT CENTER
Gastroenterology · 2023
- Mo1576 POST-TRANSPLANT OUTCOMES OF LIVER TRANSPLANTATION AMONG SUPER OBESE RECIPIENTS (BMI ≥ 50)
Gastroenterology · 2023
- Outcomes of liver diseases in pregnant females: A study from a tertiary care medical center in Pakistan
Pakistan Journal of Medical Sciences · 2023
- The American Journal of Gastroenterology×31
- Gastroenterology×21
- World Journal of Hepatology×7
- Digestive Diseases and Sciences×7
- Annals of Hepatology×5
- Lanla Conteh
Medicine · The Ohio State University
- Lindsay A. Sobotka
Medicine · The Ohio State University
- Marwan Ghabril
Medicine · Indiana University
- Eric S. Orman
Medicine · Indiana University
- Archita P. Desai
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile